RiverPoint Capital Management »

Meridian Bioscience shares owned by RiverPoint Capital Management

Quarter-by-quarter ownership of Meridian Bioscience shares owned by RiverPoint Capital Management from 13F filings

Historical chart of RiverPoint Capital Management investment in Meridian Bioscience

Tip: Access up to 7 years of quarterly data

All positions including Meridian Bioscience held by RiverPoint Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Meridian Bioscience by RiverPoint Capital Management

Quarter filed Position value Share count Share price at filing
2018-09-30 $469k 32k 14.89
2018-06-30 $500k 31k 15.91
2018-03-31 $445k 31k 14.20
2017-12-31 $428k 31k 14.00
2017-09-30 $357k 25k 14.29
2017-06-30 $365k 23k 15.75
2017-03-31 $289k 21k 13.78
2016-12-31 $360k 20k 17.68
2016-09-30 $402k 21k 19.28
2016-06-30 $395k 20k 19.48
2016-03-31 $364k 18k 20.59
2015-12-31 $401k 20k 20.51
2015-03-31 $284k 15k 19.09
2014-12-31 $182k 11k 16.47

More positions owned by RiverPoint Capital Management

Amazon (AMZN)
iShares MSCI EAFE Index Fund (EFA)
Schwab Strategic Tr us lrg cap etf (SCHX)
iShares S&P 500 Index (IVV)
iShares Russell 2000 Index (IWM)
Visa (V)
Becton, Dickinson and (BDX)
UnitedHealth (UNH)
Stryker Corporation (SYK)
TJX Companies (TJX)
Schwab International Equity ETF (SCHF)
3M Company (MMM)
Merck & Co (MRK)
Procter & Gamble Company (PG)
WisdomTree Japan SmallCap Div (DFJ)

View all positions for RiverPoint Capital Management

Top funds holding Meridian Bioscience

Huntington National Bank

View all funds holding Meridian Bioscience